{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:17:10Z","timestamp":1743826630436,"version":"3.40.3"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,4]]},"DOI":"10.7759\/cureus.81698","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T15:32:04Z","timestamp":1743780724000},"source":"Crossref","is-referenced-by-count":0,"title":["Systematic Review of Cryptococcus neoformans Seroprevalence, Antifungal Susceptibility, and Pathogenesis in Patients With HIV\/AIDS on Combination Antiretroviral Therapy in Abuja, Nigeria"],"prefix":"10.7759","author":[{"given":"Gloria C","family":"Ifiora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ijeje","family":"Sule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edediong","family":"Ekarika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chigozie  D","family":"Opara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Adebayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"New guidelines from WHO recommend a simpler, safer treatment for cryptococcal disease in people living with HIV. (2022). Accessed. October 21, 2024: https:\/\/www.who.int\/news\/item\/20-04-2022-rapid-advice-new-guidelines-for-simpler-safer-treatment-for-cryptococcal-dis...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.989265","article-title":"Prevalence of cryptococcal meningitis among people living with human immuno-deficiency virus and predictors of mortality in adults on induction therapy in Africa: A systematic review and meta-analysis","volume":"9","author":"Muzazu SG","year":"2022","unstructured":"Muzazu SG, Assefa DG, Phiri C, Getinet T, Solomon S, Yismaw G, Manyazewal T. Prevalence of cryptococcal meningitis among people living with human immuno-deficiency virus and predictors of mortality in adults on induction therapy in Africa: A systematic review and meta-analysis. Front Med (Lausanne). 2022, 9:989265. 10.3389\/fmed.2022.989265","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jof9080836","article-title":"Disseminated cryptococcosis is a common finding among human immunodeficiency virus-infected patients with suspected sepsis and is associated with higher mortality rates","volume":"9","author":"Tufa TB","year":"2023","unstructured":"Tufa TB, Orth HM, Wienemann T, et al.. Disseminated cryptococcosis is a common finding among human immunodeficiency virus-infected patients with suspected sepsis and is associated with higher mortality rates. J Fungi (Basel). 2023, 9:836. 10.3390\/jof9080836","journal-title":"J Fungi (Basel)"},{"key":"ref4","article-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","author":"Mandell GL","year":"2004","unstructured":"Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Churchill Livingstone, Philadelphia; 2004."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21767\/2573-0320.10007","article-title":"Cryptococcal neorformans antigenemia among HIV-infected patients in North Eastern Nigeria","volume":"1","author":"Goni BW","year":"2017","unstructured":"Goni BW, Kida IM, Saidu IA, et al.. Cryptococcal neorformans antigenemia among HIV-infected patients in North Eastern Nigeria. J Transm Dis Immun. 2017, 1:1-8. 10.21767\/2573-0320.10007","journal-title":"J Transm Dis Immun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020654","article-title":"Epidemiology and aetiologies of cryptococcal meningitis in Africa, 1950-2017: protocol for a systematic review","volume":"8","author":"Nyazika TK","year":"2018","unstructured":"Nyazika TK, Tatuene JK, Kenfak-Foguena A, et al.. Epidemiology and aetiologies of cryptococcal meningitis in Africa, 1950-2017: protocol for a systematic review. BMJ Open. 2018, 8:e020654. 10.1136\/bmjopen-2017-020654","journal-title":"BMJ Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham R","year":"2017","unstructured":"Rajasingham R, Smith RM, Park BJ, et al.. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017, 17:873-81. 10.1016\/S1473-3099(17)30243-8","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182926f95","article-title":"Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda","volume":"63","author":"Andama AO","year":"2013","unstructured":"Andama AO, den Boon S, Meya D, et al.. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda. J Acquir Immune Defic Syndr. 2013, 63:189-94. 10.1097\/QAI.0b013e3182926f95","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058377","article-title":"High prevalence of cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia","volume":"8","author":"Alemu AS","year":"2013","unstructured":"Alemu AS, Kempker RR, Tenna A, et al.. High prevalence of cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia. PLoS One. 2013, 8:e58377. 10.1371\/journal.pone.0058377","journal-title":"PLoS One"},{"key":"ref10","article-title":"Cryptococcus neoformans infection among human immunodeficiency virus patients on highly active antiretroviral therapy in Benin city, Nigeria","volume":"69","author":"Egbe AC","year":"2015","unstructured":"Egbe AC, Omoregie R, Alex-Ighodalo O. Cryptococcus neoformans infection among human immunodeficiency virus patients on highly active antiretroviral therapy in Benin city, Nigeria. NZJ Med Lab. 2015, 69:21-3.","journal-title":"NZJ Med Lab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062213","article-title":"Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program-Vietnam","volume":"8","author":"Smith RM","year":"2013","unstructured":"Smith RM, Nguyen TA, Ha HT, et al.. Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program-Vietnam. PLoS One. 2013, 8:e62213. 10.1371\/journal.pone.0062213","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count \u2264100 cells\/\u03bcL who start HIV therapy in resource-limited settings","volume":"51","author":"Meya DB","year":"2010","unstructured":"Meya DB, Manabe YC, Castelnuovo B, et al.. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count \u2264100 cells\/\u03bcL who start HIV therapy in resource-limited settings. Clin Infect Dis. 2010, 51:448-55. 10.1086\/655143","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw055","article-title":"Cryptococcal antigenemia in Nigerian patients with advanced human immunodeficiency virus: Influence of antiretroviral therapy adherence","volume":"3","author":"Oladele RO","year":"2016","unstructured":"Oladele RO, Akanmu AS, Nwosu AO, et al.. Cryptococcal antigenemia in Nigerian patients with advanced human immunodeficiency virus: Influence of antiretroviral therapy adherence. Open Forum Infect Dis. 2016, 3:055. 10.1093\/ofid\/ofw055","journal-title":"Open Forum Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.4103\/atp.atp_62_18","article-title":"Prevalence and factors associated with cryptococcosis among human immunodeficiency virus-infected patients of a tertiary hospital in Northwestern Nigeria","volume":"10","author":"Mohammed Y","year":"2019","unstructured":"Mohammed Y, Olayinka AT, Giwa FJ, Abubakar AA. Prevalence and factors associated with cryptococcosis among human immunodeficiency virus-infected patients of a tertiary hospital in Northwestern Nigeria. Ann Trop Pathol. 2019, 10:52-8.","journal-title":"Ann Trop Pathol"},{"key":"ref15","article-title":"Cryptococcal antigenemia among HIV seropositive patients accessing care in antiretroviral therapy (ART) clinics in Calabar, South Southern Nigeria","volume":"1","author":"Ogba OM","year":"2015","unstructured":"Ogba OM, Abia-Bassey L. Cryptococcal antigenemia among HIV seropositive patients accessing care in antiretroviral therapy (ART) clinics in Calabar, South Southern Nigeria. J Microbiol Infect. 2015, 1:2.","journal-title":"J Microbiol Infect"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"Downes MJ","year":"2016","unstructured":"Downes MJ, Brennan ML, Williams HC, Dean RS. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016, 6:e011458. 10.1136\/bmjopen-2016-011458","journal-title":"BMJ Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomized or non-randomized studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al.. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomized or non-randomized studies of healthcare interventions, or both. BMJ Open. 2017, 358:j4008. 10.1136\/bmj.j4008","journal-title":"BMJ Open"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement","volume":"134","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021, 134:103-12. 10.1016\/j.jclinepi.2021.02.003","journal-title":"J Clin Epidemiol"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.5001\/omj.2012.51","article-title":"Screening for cryptococcal antigenemia in anti-retroviral na\u00efve AIDS patients in Benin City, Nigeria","volume":"27","author":"Osazuwa F","year":"2012","unstructured":"Osazuwa F, Dirisu JO, Okuonghae PE, Ugbebor O. Screening for cryptococcal antigenemia in anti-retroviral na\u00efve AIDS patients in Benin City, Nigeria. Oman Med J. 2012, 27:228-31.","journal-title":"Oman Med J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.10203294","article-title":"Prevalence of serum cryptococcal antigen among HIV infected patients attending a university of Benin Teaching Hospital, Edo state, Nigeria","volume":"68","author":"Constance OC","year":"2023","unstructured":"Constance OC, Emmanuel M, Ubulu MB. Prevalence of serum cryptococcal antigen among HIV infected patients attending a university of Benin Teaching Hospital, Edo state, Nigeria. Acta Microbiol Hell. 2023, 68:248-60. 10.5281\/zenodo.10203294","journal-title":"Acta Microbiol Hell"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/471363","article-title":"New insights into HIV\/AIDS-associated cryptococcosis","volume":"2013","author":"Antinori S","year":"2013","unstructured":"Antinori S. New insights into HIV\/AIDS-associated cryptococcosis. ISRN AIDS. 2013, 2013:471363. 10.1155\/2013\/471363","journal-title":"ISRN AIDS"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4314\/njm.v19i4.61963","article-title":"Frequency of cryptococcal meningitis in HIV-1 infected patients in north central Nigeria","volume":"19","author":"Gomerep SS","year":"2010","unstructured":"Gomerep SS, Idoko JA, Ladep NG, et al.. Frequency of cryptococcal meningitis in HIV-1 infected patients in north central Nigeria. Niger J Med. 2010, 19:395-9. 10.4314\/njm.v19i4.61963","journal-title":"Niger J Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1723920","article-title":"A study of clearance of infection in HIV-associated cryptococcal meningitis after amphotericin-based induction and fluconazole-based consolidation therapy","volume":"7","author":"Devi SB","year":"2021","unstructured":"Devi SB, Navi RA, Suraj T, Reema N, Singh TG, Kuotsu MM, Konyak N. A study of clearance of infection in HIV-associated cryptococcal meningitis after amphotericin-based induction and fluconazole-based consolidation therapy. Int J Recent Surg Med Sci. 2021, 7:23-33. 10.1055\/s-0041-1723920","journal-title":"Int J Recent Surg Med Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-023-01073-4","article-title":"Cryptococcus neoformans, a global threat to human health","volume":"12","author":"Zhao Y","year":"2023","unstructured":"Zhao Y, Ye L, Zhao F, et al.. Cryptococcus neoformans, a global threat to human health. Infect Dis Poverty. 2023, 12:20. 10.1186\/s40249-023-01073-4","journal-title":"Infect Dis Poverty"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir903","article-title":"High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand","volume":"54","author":"Harris JR","year":"2012","unstructured":"Harris JR, Lindsley MD, Henchaichon S, et al.. High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand. Clin Infect Dis. 2012, 54:43-50. 10.1093\/cid\/cir903","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2012.761737","article-title":"Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil","volume":"51","author":"Andrade-Silva L","year":"2013","unstructured":"Andrade-Silva L, Ferreira-Paim K, Mora DJ, et al.. Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil. Med Mycol. 2013, 51:635-40. 10.3109\/13693786.2012.761737","journal-title":"Med Mycol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019760","article-title":"Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis","volume":"4","author":"Kwon-Chung KJ","year":"2014","unstructured":"Kwon-Chung KJ, Fraser JA, Doering TL, Wang Z, Janbon G, Idnurm A, Bahn YS. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med. 2014, 4:a019760. 10.1101\/cshperspect.a019760","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005223","article-title":"MLST-based population genetic analysis in a global context reveals clonality amongst Cryptococcus neoformans var. grubii VNI isolates from HIV patients in Southeastern Brazil","volume":"11","author":"Ferreira-Paim K","year":"2017","unstructured":"Ferreira-Paim K, Andrade-Silva L, Fonseca FM, et al.. MLST-based population genetic analysis in a global context reveals clonality amongst Cryptococcus neoformans var. grubii VNI isolates from HIV patients in Southeastern Brazil. PLoS Negl Trop Dis. 2017, 11:e0005223. 10.1371\/journal.pntd.0005223","journal-title":"PLoS Negl Trop Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad351","article-title":"Prevalence and factors associated with cryptoccocal antigenemia among patients with advanced human immunodeficiency virus in eastern Uganda: a facility-based cross-sectional  study","volume":"10","author":"Eric E","year":"2023","unstructured":"Eric E, Olupot-Olupot P, Bwayo D, Meya D, Katuramu R. Prevalence and factors associated with cryptoccocal antigenemia among patients with advanced human immunodeficiency virus in eastern Uganda: a facility-based cross-sectional  study. Open Forum Infect Dis. 2023, 10:ofad351. 10.1093\/ofid\/ofad351","journal-title":"Open Forum Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s40475-015-0045-z","article-title":"Preventing cryptococcosis\u2014shifting the paradigm in the era of highly active antiretroviral therapy","volume":"2","author":"Meya D","year":"2015","unstructured":"Meya D, Rajasingham R, Nalintya E, Tenforde M, Jarvis JN. Preventing cryptococcosis\u2014shifting the paradigm in the era of highly active antiretroviral therapy. Curr Trop Med Rep. 2015, 2:81-9. 10.1007\/s40475-015-0045-z","journal-title":"Curr Trop Med Rep"},{"key":"ref31","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan JE","year":"2009","unstructured":"Kaplan JE, Benson C, Holmes KK, et al.. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009, 58:1-207.","journal-title":"MMWR Recomm Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/jof8121284","article-title":"Prevalence and associated factors of cryptococcal antigenemia in HIV-infected patients with CD4 <200 cells\/\u00b5L in S\u00e3o Paulo, Brazil: a Bayesian analysis","volume":"8","author":"Mimicos EV","year":"2022","unstructured":"Mimicos EV, Fossaluza V, Picone CM, et al.. Prevalence and associated factors of cryptococcal antigenemia in HIV-infected patients with CD4 &lt;200 cells\/\u00b5L in S\u00e3o Paulo, Brazil: a Bayesian analysis. J Fungi (Basel). 2022, 8:1284. 10.3390\/jof8121284","journal-title":"J Fungi (Basel)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v20i1.16","article-title":"Magnitude of cryptococcosis among HIV patients in Sub-Saharan Africa countries: a systematic review and meta-analysis","volume":"20","author":"Alemayehu T","year":"2020","unstructured":"Alemayehu T, Ayalew S, Buzayehu T, Daka D. Magnitude of cryptococcosis among HIV patients in Sub-Saharan Africa countries: a systematic review and meta-analysis. Afr Health Sci. 2020, 20:114-21. 10.4314\/ahs.v20i1.16","journal-title":"Afr Health Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00342-10","article-title":"Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts","volume":"2","author":"D'Souza CA","year":"2011","unstructured":"D'Souza CA, Kronstad JW, Taylor G, et al.. Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. mBio. 2011, 2:e00342-10. 10.1128\/mBio.00342-10","journal-title":"mBio"},{"key":"ref35","article-title":"Cryptococcal infections in non-HIV-infected patients","volume":"124","author":"Pappas PG","year":"2013","unstructured":"Pappas PG. Cryptococcal infections in non-HIV-infected patients. Trans Am Clin Climatol Assoc. 2013, 124:61-79.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2015.10.006","article-title":"Cryptococcosis","volume":"30","author":"Maziarz EK","year":"2016","unstructured":"Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2016, 30:179-206. 10.1016\/j.idc.2015.10.006","journal-title":"Infect Dis Clin North Am"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2010.01946.x","article-title":"Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya","volume":"54","author":"Mdodo R","year":"2011","unstructured":"Mdodo R, Moser SA, Jaoko W, et al.. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya. Mycoses. 2011, 54:e438-42. 10.1111\/j.1439-0507.2010.01946.x","journal-title":"Mycoses"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.723251","article-title":"High prevalence of HIV-related cryptococcosis and increased resistance to fluconazole of the Cryptococcus neoformans complex in Jiangxi Province, South Central China","volume":"11","author":"Yang C","year":"2021","unstructured":"Yang C, Bian Z, Blechert O, et al.. High prevalence of HIV-related cryptococcosis and increased resistance to fluconazole of the Cryptococcus neoformans complex in Jiangxi Province, South Central China. Front Cell Infect Microbiol. 2021, 11:723251. 10.3389\/fcimb.2021.723251","journal-title":"Front Cell Infect Microbiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2012.02.018","article-title":"Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility","volume":"73","author":"Lockhart SR","year":"2012","unstructured":"Lockhart SR, Iqbal N, Bolden CB, et al.. Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility. Diagn Microbiol Infect Dis. 2012, 73:144-8. 10.1016\/j.diagmicrobio.2012.02.018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/jof8070734","article-title":"Cryptococcus neoformans genotypic diversity and disease outcome among HIV patients in Africa","volume":"8","author":"Kassaza K","year":"2022","unstructured":"Kassaza K, Wasswa F, Nielsen K, Bazira J. Cryptococcus neoformans genotypic diversity and disease outcome among HIV patients in Africa. J Fungi (Basel). 2022, 8:734. 10.3390\/jof8070734","journal-title":"J Fungi (Basel)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/jof9030364","article-title":"Importance of clinical isolates in Cryptococcus neoformans research","volume":"9","author":"Jackson KM","year":"2023","unstructured":"Jackson KM, Ding M, Nielsen K. Importance of clinical isolates in Cryptococcus neoformans research. J Fungi (Basel). 2023, 9:364-376. 10.3390\/jof9030364","journal-title":"J Fungi (Basel)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-67","article-title":"Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases","volume":"10","author":"Jarvis JN","year":"2010","unstructured":"Jarvis JN, Meintjes G, Williams A, Brown Y, Crede T, Harrison TS. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis. 2010, 10:67. 10.1186\/1471-2334-10-67","journal-title":"BMC Infect Dis"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s40588-016-0035-5","article-title":"HIV-associated cryptococcal meningitis: bridging the gap between developed and resource-limited settings","volume":"3","author":"Tenforde MW","year":"2016","unstructured":"Tenforde MW, Wake R, Leeme T, Jarvis JN. HIV-associated cryptococcal meningitis: bridging the gap between developed and resource-limited settings. Curr Clin Microbiol Rep. 2016, 3:92-102. 10.1007\/s40588-016-0035-5","journal-title":"Curr Clin Microbiol Rep"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.4161\/viru.18685","article-title":"Molecular mechanisms of cryptococcal meningitis","volume":"3","author":"Liu TB","year":"2012","unstructured":"Liu TB, Perlin DS, Xue C. Molecular mechanisms of cryptococcal meningitis. Virulence. 2012, 3:173-81. 10.4161\/viru.18685","journal-title":"Virulence"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1128\/EC.00103-15","article-title":"Virulence-associated enzymes of Cryptococcus neoformans","volume":"14","author":"Almeida F","year":"2015","unstructured":"Almeida F, Wolf JM, Casadevall A. Virulence-associated enzymes of Cryptococcus neoformans. Eukaryot Cell. 2015, 14:1173-85. 10.1128\/EC.00103-15","journal-title":"Eukaryot Cell"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/jof8101069","article-title":"Cryptococcus neoformans infection in the central nervous system: the battle between host and pathogen","volume":"8","author":"Chen Y","year":"2022","unstructured":"Chen Y, Shi ZW, Strickland AB, Shi M. Cryptococcus neoformans infection in the central nervous system: the battle between host and pathogen. J Fungi. 2022, 8:1069. 10.3390\/jof8101069","journal-title":"J Fungi"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01649-14","article-title":"Identification of Aph1, a phosphate-regulated, secreted, and vacuolar acid phosphatase in Cryptococcus neoformans","volume":"5","author":"Lev S","year":"2014","unstructured":"Lev S, Crossett B, Cha SY, et al.. Identification of Aph1, a phosphate-regulated, secreted, and vacuolar acid phosphatase in Cryptococcus neoformans. mBio. 2014, 5:e01649-14. 10.1128\/mBio.01649-14","journal-title":"mBio"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004037","article-title":"A role for LHC1 in higher order structure and complement binding of the Cryptococcus neoformans capsule","volume":"10","author":"Park YD","year":"2014","unstructured":"Park YD, Shin S, Panepinto J, et al.. A role for LHC1 in higher order structure and complement binding of the Cryptococcus neoformans capsule. PLoS Pathog. 2014, 10:e1004037. 10.1371\/journal.ppat.1004037","journal-title":"PLoS Pathog"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01101-14","article-title":"Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease","volume":"5","author":"Vu K","year":"2014","unstructured":"Vu K, Tham R, Uhrig JP, et al.. Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease. mBio. 2014, 5:e01101-14. 10.1128\/mBio.01101-14","journal-title":"mBio"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/jof10110786","article-title":"Roles of different signaling pathways in Cryptococcus neoformans virulence","volume":"10","author":"Mahmood F","year":"2024","unstructured":"Mahmood F, Chen JM, Al-Huthaifi AM, Al-Alawi AA, Liu TB. Roles of different signaling pathways in Cryptococcus neoformans virulence. J Fungi (Basel). 2024, 10:786. 10.3390\/jof10110786","journal-title":"J Fungi (Basel)"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.riam.2009.11.004","article-title":"Extracellular DNase activity of Cryptococcus neoformans and Cryptococcus gattii","volume":"27","author":"S\u00e1nchez M","year":"2010","unstructured":"S\u00e1nchez M, Colom F. Extracellular DNase activity of Cryptococcus neoformans and Cryptococcus gattii. Rev Iberoam Micol. 2010, 27:10-3. 10.1016\/j.riam.2009.11.004","journal-title":"Rev Iberoam Micol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007144","article-title":"Cryptococcus neoformans urease affects the outcome of intracellular pathogenesis by modulating phagolysosomal pH","volume":"14","author":"Fu MS","year":"2018","unstructured":"Fu MS, Coelho C, De Leon-Rodriguez CM, et al.. Cryptococcus neoformans urease affects the outcome of intracellular pathogenesis by modulating phagolysosomal pH. PLoS Pathog. 2018, 14:e1007144. 10.1371\/journal.ppat.1007144","journal-title":"PLoS Pathog"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.imr.2018.01.008","article-title":"Zinc, copper, CD4 T-cell count and some hematological parameters of HIV-infected subjects in Southern Nigeria","volume":"7","author":"Asemota EA","year":"2018","unstructured":"Asemota EA, Okafor IM, Okoroiwu HU, Ekong ER, Anyanwu SO, Efiong EE, Udomah F. Zinc, copper, CD4 T-cell count and some hematological parameters of HIV-infected subjects in Southern Nigeria. Integr Med Res. 2018, 7:53-60. 10.1016\/j.imr.2018.01.008","journal-title":"Integr Med Res"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002983","article-title":"The Joint United Nations Programme on HIV\/AIDS 95-95-95 targets: worldwide clinical and cost benefits of generic manufacture","volume":"35","author":"Heath K","year":"2021","unstructured":"Heath K, Levi J, Hill A. The Joint United Nations Programme on HIV\/AIDS 95-95-95 targets: worldwide clinical and cost benefits of generic manufacture. AIDS. 2021, 35:S197-203. 10.1097\/QAD.0000000000002983","journal-title":"AIDS"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/351043","article-title":"Serum micronutrient status of Haart-na\u00efve, HIV infected children in South Western Nigeria: a case controlled study","volume":"2014","author":"Anyabolu HC","year":"2014","unstructured":"Anyabolu HC, Adejuyigbe EA, Adeodu OO. Serum micronutrient status of Haart-na\u00efve, HIV infected children in South Western Nigeria: a case controlled study. AIDS Res Treat. 2014, 2014:351043. 10.1155\/2014\/351043","journal-title":"AIDS Res Treat"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s40588-017-0064-8","article-title":"Cryptococcosis today: it is not all about HIV infection","volume":"4","author":"O'Halloran JA","year":"2017","unstructured":"O'Halloran JA, Powderly WG, Spec A. Cryptococcosis today: it is not all about HIV infection. Curr Clin Microbiol Rep. 2017, 4:88-95. 10.1007\/s40588-017-0064-8","journal-title":"Curr Clin Microbiol Rep"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.2174\/18746136-v16-e2204120","article-title":"Adjunct therapy of zinc supplementation increases immunological response in HIV-infected patients: a systematic review and meta-analysis","volume":"16","author":"Sindhughosa DA","year":"2022","unstructured":"Sindhughosa DA, Somia I, Merati KTP, Suryana K. Adjunct therapy of zinc supplementation increases immunological response in HIV-infected patients: a systematic review and meta-analysis. Open AIDS J. 2022, 16:1-12. 10.2174\/18746136-v16-e2204120","journal-title":"Open AIDS J"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1309\/LMM55QSHUTTX1OEA","article-title":"Comparison of CD4+ cell count in pregnant HIV-seropositive and HIV-seronegative Nigerian women","volume":"43","author":"Ekwempu AI","year":"2012","unstructured":"Ekwempu AI, Ekwempu CC, Ikeh E, Olabode A, Agaba E. Comparison of CD4+ cell count in pregnant HIV-seropositive and HIV-seronegative Nigerian women. Lab Med. 2012, 43:168-71. 10.1309\/LMM55QSHUTTX1OEA","journal-title":"Lab Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1590\/S0036-46652015000400007","article-title":"Serum level of copper and iron in dengue fever","volume":"57","author":"Soundravally R","year":"2015","unstructured":"Soundravally R, Sherin J, Agieshkumar BP, et al.. Serum level of copper and iron in dengue fever. Rev Inst Med Trop Sao Paulo. 2015, 57:315-20. 10.1590\/S0036-46652015000400007","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref60","article-title":"Prevalence, severity, and related factors of anemia in HIV\/AIDS patients","volume":"17","author":"Meidani M","year":"2012","unstructured":"Meidani M, Rezaei F, Maracy MR, Avijgan M, Tayeri K. Prevalence, severity, and related factors of anemia in HIV\/AIDS patients. J Res Med Sci. 2012, 17:138-42.","journal-title":"J Res Med Sci"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.9734\/IJTDH\/2015\/19657","article-title":"Prevalence of anemia among human immunodeficiency virus infected patients accessing healthcare in Federal Medical Centre Keffi, Nigeria","volume":"10","author":"Pennap GR","year":"2015","unstructured":"Pennap GR, Abubakar K . Prevalence of anemia among human immunodeficiency virus infected patients accessing healthcare in Federal Medical Centre Keffi, Nigeria. Int J Trop Dis Health. 2015, 10:1-7. 10.9734\/IJTDH\/2015\/19657","journal-title":"Int J Trop Dis Health"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.4081\/jbr.2017.6210","article-title":"Some hematological parameters of Wistar rats treated with Chromolaena odorata leave extracts","volume":"90","author":"Okoroiwu HU","year":"2017","unstructured":"Okoroiwu HU, Okafor IM, Uko EK, Atang IJ . Some hematological parameters of Wistar rats treated with Chromolaena odorata leave extracts. J Biol Res. 2017, 90:51-5. 10.4081\/jbr.2017.6210","journal-title":"J Biol Res"},{"key":"ref63","article-title":"Levels of serum zinc, copper and copper\/zinc ratio in patients with diarrhea and HIV infection in Ethiopia","volume":"1","author":"Amare B","year":"2011","unstructured":"Amare B, Tafess K, Moges F, Moges B, Yabutani T, Ota F, Kassu A. Levels of serum zinc, copper and copper\/zinc ratio in patients with diarrhea and HIV infection in Ethiopia. Vitam Trace Elem. 2011, 1:101.","journal-title":"Vitam Trace Elem"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12039","article-title":"First environmental isolation of Cryptococcus gattii, genotype AFLP5, from India and a global review","volume":"56","author":"Chowdhary A","year":"2013","unstructured":"Chowdhary A, Prakash A, Randhawa HS, Kathuria S, Hagen F, Klaassen CH, Meis JF. First environmental isolation of Cryptococcus gattii, genotype AFLP5, from India and a global review. Mycoses. 2013, 56:222-8. 10.1111\/myc.12039","journal-title":"Mycoses"},{"key":"ref65","article-title":"Studies on trace elements metabolism in HIV\/AIDS disease in Nigeria","volume":"2","author":"Ibeh IN","year":"2012","unstructured":"Ibeh IN, Abuo A, Isitua CC. Studies on trace elements metabolism in HIV\/AIDS disease in Nigeria. Prime J Microbiol Res. 2012, 2:86-92.","journal-title":"Prime J Microbiol Res"},{"key":"ref66","article-title":"Nutritional indices and cardiovascular risk factors in HIV infection in Southern Nigeria","volume":"2","author":"Nsonwu-Anyanwu AC","year":"2017","unstructured":"Nsonwu-Anyanwu AC, Egbe ER, Agu CE, Offor SJ, Usoro CA, Essien IA, Okon CA. Nutritional indices and cardiovascular risk factors in HIV infection in Southern Nigeria. J Immunol Microbiol. 2017, 2:34-42.","journal-title":"J Immunol Microbiol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-014-1615-2","article-title":"Antiviral strategies against influenza virus: towards new therapeutic approaches","volume":"71","author":"Loregian A","year":"2014","unstructured":"Loregian A, Mercorelli B, Nannetti G, Compagnin C, Pal\u00f9 G. Antiviral strategies against influenza virus: towards new therapeutic approaches. Cell Mol Life Sci. 2014, 71:3659-83. 10.1007\/s00018-014-1615-2","journal-title":"Cell Mol Life Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/317359-systematic-review-of-cryptococcus-neoformans-seroprevalence-antifungal-susceptibility-and-pathogenesis-in-patients-with-hivaids-on-combination-antiretroviral-therapy-in-abuja-nigeria","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T15:32:24Z","timestamp":1743780744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/317359-systematic-review-of-cryptococcus-neoformans-seroprevalence-antifungal-susceptibility-and-pathogenesis-in-patients-with-hivaids-on-combination-antiretroviral-therapy-in-abuja-nigeria"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":67,"URL":"https:\/\/doi.org\/10.7759\/cureus.81698","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,4]]}}}